US BANCORP \DE\

Bank

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 36104 MINNEAPOLIS, MN

Position in BCRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,540

+$293 QoQ

Shares Held

154

+17.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#297

of 316 holders

Holding Since

Jun 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $34,968,542 across 41 Drug Manufacturers - Specialty & Generic names. BCRX ranks #33 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	466,714	$7,481,424
2	HLN	Haleon plc	650,820	$6,072,149
3	TEVA	Teva Pharmaceutical Industries Ltd	155,892	$5,281,619
4	ZTS	Zoetis Inc.	54,002	$3,880,582
5	VTRS	Viatris Inc	220,066	$3,494,647
6	RDY	Dr Reddys Laboratories Ltd	189,028	$2,739,015
7	LNTH	Lantheus Holdings, Inc.	11,941	$1,324,734
8	HIMS	Hims & Hers Health, Inc.	29,837	$1,034,448

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,540	154	+17.6%	Shares	Defined	2026-08-12
2026-03-31	$1,247	131	-51.7%	Shares	Defined	2026-05-15
2025-06-30	$2,428	271	+29.0%	Shares	Defined	2025-07-24
2024-12-31	$1,579	210	-81.3%	Shares	Defined	2025-02-05
2023-03-31	$9,390	1,126	+1240.5%	Shares	Defined	2023-05-09
2022-12-31	$964	84	-24.3%	Shares	Defined	2023-02-13
2022-09-30	$1,398	111	+32.1%	Shares	Defined	2022-10-27
2022-06-30	$888	84	-99.3%	Shares	Defined	2022-08-01
2022-03-31	$196,746	12,100	+4.3%	Shares	Defined	2022-05-11
2021-12-31	$160,660	11,600	+35.0%	Shares	Defined	2022-02-11
2021-09-30	$123,495	8,594	+2.3%	Shares	Defined	2021-11-10
2021-06-30	$132,804	8,400	-26.3%	Shares	Defined	2021-08-05
2021-03-31	$115,938	11,400	+470.0%	Shares	Defined	2021-04-28
2020-12-31	$14,900	2,000	+100.0%	Shares	Defined	2021-02-04
2020-06-30	$4,760	1,000	—	Shares	Defined	2020-08-07
No filing history on record for this holder in this stock.